China-based Lee’s Pharmaceutical Holdings Ltd (HKG: 0950) subsidiary, Zhaoke Ophthalmology Ltd (HKG: 6622), has entered into a partnership with Beijing-headquartered ophthalmic device manufacturer, Eyebright Medical Technology Co., Ltd (SHA: 688050). The collaboration aims to enhance the development and commercialization of ophthalmic drugs and medical devices.
Comprehensive Collaboration in Ophthalmology
Under the terms of the agreement, the two firms will work together extensively within the ophthalmology sector, exploring opportunities to jointly research, develop, and commercialize ophthalmology products. The partnership also includes the promotion of Zhaoke’s products in eye hospitals, eye clinics, optical centers, and other relevant establishments. Financial details of the deal have not been disclosed.
Zhaoke’s NVK002 in Phase III for Myopia Control
Zhaoke Ophthalmology boasts a significant product in its pipeline, NVK002, which is currently undergoing a Phase III study focused on arresting myopia in children and adolescents. This development highlights the company’s commitment to addressing critical eye health issues and its dedication to advancing ophthalmic care.-Fineline Info & Tech